Menu Search
Equities

Adapthealth Corp

AHCO:NAQ

Adapthealth Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)9.89
  • Today's Change0.17 / 1.75%
  • Shares traded539.71k
  • 1 Year change+18.87%
  • Beta1.1125
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Adapthealth Corp had net income fall from a gain of 69.32m to a loss of 678.90m despite a 7.73% increase in revenues from 2.97bn to 3.20bn. An increase in the selling, general and administrative costs as a percentage of sales from 7.43% to 7.96% was a component in the falling net income despite rising revenues.
Gross margin19.03%
Net profit margin-6.44%
Operating margin-2.45%
Return on assets-4.57%
Return on equity-13.41%
Return on investment-5.14%
More ▼

Cash flow in USDView more

In 2023, Adapthealth Corp increased its cash reserves by 66.69%, or 30.86m. The company earned 480.67m from its operations for a Cash Flow Margin of 15.02%. In addition the company used 357.28m on investing activities and also paid 92.53m in financing cash flows.
Cash flow per share1.22
Price/Cash flow per share8.07
Book value per share11.27
Tangible book value per share-9.70
More ▼

Balance sheet in USDView more

Adapthealth Corp has a Debt to Total Capital ratio of 57.57%, a lower figure than the previous year's 123.66%.
Current ratio1.24
Quick ratio0.9951
Total debt/total equity1.36
Total debt/total capital0.5757
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.